Navigation Links
Encouraging Prospects for Medical Imaging Equipment Services in Europe
Date:12/2/2008

LONDON, Dec. 2 /PRNewswire/ -- Services form an integral part of most of original equipment manufacturers' (OEMs') revenues. It has therefore become essential for service providers in the European medical imaging services market to remain competitive and constantly improve their services and contract penetration rates.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicalimaging.frost.com) European Medical Imaging Equipment Services Market, finds that the market earned revenues of $1.52 billion in 2007 and estimates this to reach $1.98 billion in 2014.

"The increase in high-end modality installations will spur growth in the related services market," notes Frost & Sullivan Research Analyst Smruti Munshi. "In particular, the expansion in high-end modality installations for magnetic resonance imaging (MRI) and computed tomography (CT) is a solid driver for the European medical imaging equipment services market."

As hospitals and other healthcare organisations want to keep pace with new developments and maintain state-of-the-art equipment, they opt for timely software and hardware upgrades. They also want to be prepared for the anticipated increase in the number of applications and improvements in diagnosis and image quality.

"The one-size fits all approach is no longer applicable as customers seek a more personal approach and customised service solutions," says Munshi. "The different healthcare scenarios where medical imaging is performed should be studied properly by service providers to plan flexible service contracts."

The installation of high-end modalities such as CT and MRI in hospitals requires specially planned and equipped rooms with designed inf
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New electronic health records demonstration project encouraging step says ACP
2. Tubbs Jones Introduces Resolution Encouraging STD Prevention
3. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
4. Health and Fitness Industry Gets Moving on Capitol Hill to Champion Legislation Encouraging Exercise
5. Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
6. Sanderson Farms Launches New Summer Program Encouraging Families to Get Healthy
7. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
8. Hormone Normalization Shows Encouraging Effects In Documented Clinically Deficient Men/Women
9. QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
10. Bright tumors, dim prospects
11. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... ReverseAges.com launches new content to inc...l fatigue, and how to best deal with these health ...PRWEB) July 3, 2009 -- ReverseAges.com has recentl...ain the dangers of common health issues such as hi...y a variety of factors, and the new content on Rev...
(Date:7/3/2009)... Julian Whitaker, MD, a founder of the alter...n searchjointpain.com, a new informational Web sit...tions and solutions. , Po... MD, a founder of the alternative health movement,...a new informational Web site devoted to all aspect...
(Date:7/3/2009)... As the health care reform details emerge, m...ance for small groups and business insurance premi...rning to websites such as the Small Business Healt... Minneapolis, Minn. (PRWEB) July 3,...sidered by the House, which has entrepreneurs worr...
(Date:7/2/2009)... State Leaders to Support Principles to Govern Hea...ly 2 Nearly nine out of...mpanies have too much influence over how doctors c...voters support the concept of a "Health Insurer Co...ing principles for health insurance companies with...
Breaking Medicine News(10 mins):Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6
...ne of the leading developmental disability. Statis...ts suffer from autism. In US there is a 10-17% inc...he disease has been studied widely and its symptom...f the disease still remains a mystery. A new mode...
...Temple University researchers has found that Afric...even though they smoke less cigarettes than Caucas.../. The study, which confirms findings from a small...ar, also offers evidence of biological differences...
...ospitals in Spain are taking part in an initiative...r in the blood of people who have suffered a strok...e IV International Meeting on Isquemic Ictus. The ... Autonomous Communities and that had suffered a st...
...rrix suffers from Hodgkin's disease, a cancer of t...th a knot on his neck that turned out to be a swol...ts revealed that he also had a tumor near his wind...e nearest children's hospital to undergo chemother...
Other Medicine News:Health News:iSTART Brain Model Reveals the possible Cause of Autism 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 3Health News:African Americans Have Increased Risk Of Emphysema 2Health News:US Boy Wants the Right of Choice of Treatment 2
(Date:7/3/2009)...ewswire/ -- BioCis Pharma Ltd., a privately,held ...Turku, Finland,announced positive results from i...sion cream, the company,s novel topical drug for d... study, conducted in Finland, included 13,patient...ied the ProtoCure,emulsion cream to the affected ...
(Date:7/2/2009)...n., July 2 Acura Pharmac...uticals, Inc. (NYSE: KG ) announced today that t...ued a Complete Response Letter regarding the New D...SP and niacin, USP) Tablets CII, an immediate rele...-severe pain. , , (Logo: http://www.newsco...
(Date:7/1/2009)... The largest study of,th...vealed several new common,single-letter variants ...to,risk of the disease. The study, by a multinati...deCODE genetics (Nasdaq: DCGN ), analyzed the gen...ticipants from fourteen countries.,It is publishe...
(Date:6/30/2009)...wswire/ -- If you have been eating Garlic to keep ...While there is absolutely no scientific evidence t...spraying garlic has plenty of evidence to prove it...on grassy lawns is not as strange as it seems. Mos..., Inc. is being used successfully by city parks, g...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Par Pharmaceutical Reports Third Quarter 2007 Results 8597 1Par Pharmaceutical Reports Third Quarter 2007 Results 8597 2Par Pharmaceutical Reports Third Quarter 2007 Results 8597 3Par Pharmaceutical Reports Third Quarter 2007 Results 8597 4Par Pharmaceutical Reports Third Quarter 2007 Results 8597 5Par Pharmaceutical Reports Third Quarter 2007 Results 8597 6Par Pharmaceutical Reports Third Quarter 2007 Results 8597 7Par Pharmaceutical Reports Third Quarter 2007 Results 8597 8Par Pharmaceutical Reports Third Quarter 2007 Results 8597 9Par Pharmaceutical Reports Third Quarter 2007 Results 8597 10Par Pharmaceutical Reports Third Quarter 2007 Results 8597 11Par Pharmaceutical Reports Third Quarter 2007 Results 8597 12Exelixis Submits XL139 Diligence Report to Bristol Myers Squibb 2325 1Exelixis Submits XL139 Diligence Report to Bristol Myers Squibb 2325 2Exelixis Submits XL139 Diligence Report to Bristol Myers Squibb 2325 3Exelixis Submits XL139 Diligence Report to Bristol Myers Squibb 2325 4Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS ETR1 in Combination With Chemotherapy 2320 1Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS ETR1 in Combination With Chemotherapy 2320 2Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS ETR1 in Combination With Chemotherapy 2320 3Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS ETR1 in Combination With Chemotherapy 2320 4Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS ETR1 in Combination With Chemotherapy 2320 5Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS ETR1 in Combination With Chemotherapy 2320 6Insurance status linked to cancer outcomes 8591 1Insurance status linked to cancer outcomes 8591 2Insurance status linked to cancer outcomes 8591 3Insurance status linked to cancer outcomes 8591 4Insurance status linked to cancer outcomes 8591 5
...IRVING, Texas--(BUSINESS WIRE)--May 15, 2007 - Rea...cation of an article,in the May 2007 issue of the ...company,s Phase 2 development candidate for cancer...of breast cancer,and that the drug inhibits signal... cancer therapies., The article, "The Novel Triter...
...RALEIGH, N.C.--(BUSINESS WIRE)--May 17, 2007 - Sal...nced that results of,18 investigator-initiated tri...ented at Digestive Disease Week(R) 2007, which wil...is considered the,largest and most prestigious mee...ear it attracts more than 16,000 physicians,resea...
Other Medicine Technology:RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 2RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
Accu-Temp Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap to lo
Accu-Temp® Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap
Accu-Temp Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap to lo
Accu-Temp Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap to lo
Medicine Products: